Highlights
TSXV: ATE       Antibe Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.425   +0.005 (1.19%)  0.42 - 0.44  238,252

Overview

 
Avg Volume (4 weeks):0
52 Weeks Range:0.24 - 0.44
52 Weeks Price Volatility (%):
92.50%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Antibe Therapeutics Inc is a healthcare company. It is engaged in the development of patents and out-licensing of improved compounds of existing drugs. Its product includes ATB-346 a hydrogen sulfide-releasing derivative of naproxen. The company has two primary business segments: Antibe Therapeutics, a pharmaceutical development company, and Citagenix, a marketer and distributor of regenerative medicines serving the dental and orthopedic marketplaces.

  Be the first to like this.
 


 

799  763  1303  1681 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ENB 51.37+0.70 
 MFC 26.26-0.12 
 ECA 5.86-0.11 
 K 5.65-0.03 
 ACB 4.69-0.02 
 ABX 22.08+0.33 
 GOOS 46.13-5.65 
 VUL 0.105+0.025 
 OGI 3.33-0.24 
 YRI 4.52+0.09 
Partners & Brokers